Mode
Text Size
Log in / Sign up

Biological heterogeneity and overlapping phenotypes complicate the classification of allergic rhinitis casesNew research shows allergic rhinitis is more complex than once thought

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize that overlapping phenotypes and biological heterogeneity may complicate the classification of allergic rhinitis.

This narrative review examines the biological complexity of the nasal mucosa in patients with allergic rhinitis. The authors argue that allergic rhinitis is not a single cytological expression but involves complex interactions between epithelial cells, innate and adaptive lymphoid populations, mast cells, eosinophils, stromal elements, and vascular components.

Furthermore, the review highlights that allergic sensitization can coexist with non-allergic rhinitis entities, such as NARES, NARMA, and NARESMA. This overlap challenges the traditional binary classification of allergic versus non-allergic rhinitis. The authors note that while these cytologically defined entities are not synonymous with molecular endotypes, they represent significant clinical complexities.

Clinically, the review suggests that nasal cytology may serve as a useful interface between clinical phenotyping and molecular endotyping. This approach may help clinicians manage difficult-to-treat cases or patients with incomplete therapeutic responses. However, the evidence is based on a narrative review of existing literature, and the specific limitations of the underlying data are not detailed.

How this fits prior evidence

This narrative review addresses a gap in the clinical understanding of allergic rhinitis by highlighting the complexity of nasal mucosa biology. While prior coverage identified specific targets like tissue-resident memory T cells and macrophage metabolic reprogramming, this review emphasizes that allergic rhinitis involves diverse interactions between multiple cell types and stromal elements. It also notes that overlapping features with non-allergic entities complicate simple classifications, potentially impacting how clinicians approach cases with incomplete therapeutic responses.

If you suffer from allergic rhinitis, you know it is not always a simple case of pollen or dust causing a sneeze. New research highlights that the condition is much more complex than a simple allergic versus non-allergic split. It involves a complicated interaction between different types of cells in the nasal lining, including immune cells and blood vessel components.

Because the condition is so diverse, many people have overlapping symptoms. Some people may have allergic reactions while also showing signs of non-allergic rhinitis. This makes it hard for doctors to give a simple label to every patient. This complexity is why some people find it hard to get their symptoms under control with standard treatments.

Looking closely at the cells in the nose can help doctors better understand a patient's specific type of rhinitis. By moving past a simple label, doctors may be able to better identify why some cases are harder to treat. This approach aims to help patients who do not see full results from their current medications.

What this means for you:
Allergic rhinitis involves many different cell types and overlapping symptoms, making it a complex condition to treat.

Common questions

Why is allergic rhinitis so hard to treat for some people?

It is hard to treat because allergic rhinitis is not a single condition. It involves a complex mix of different cells in the nasal lining, such as immune cells and blood vessel components. Because it is so diverse, a simple treatment might not work for everyone.

Can someone have both allergic and non-allergic symptoms?

Yes, allergic reactions can exist at the same time as non-allergic rhinitis. This overlap makes it difficult to use a simple allergic versus non-allergic classification. Because these conditions often overlap, patients may have a mix of symptoms that are hard to categorize.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Allergic rhinitis is traditionally defined by allergen sensitization and type 2 inflammation, yet increasing evidence indicates that this framework does not fully capture the biological heterogeneity of the nasal mucosa. The local inflammatory landscape reflects a dynamic interaction among epithelial cells, innate and adaptive lymphoid populations, mast cells, eosinophils, stromal elements, and vascular components, and may diverge substantially from systemic biomarkers. Recent single-cell and multi-omic studies have further revealed disease-associated alterations in epithelial differentiation, stromal activation, and cell-cell communication, reinforcing the concept of the nasal mucosa as an integrated immunological ecosystem. Within this context, mast cell-eosinophil interactions appear particularly relevant, as their coexistence and degranulation may characterize inflammatory states that differ from isolated eosinophilia. Nasal cytology provides a clinically accessible morphological readout of this local cellular architecture and has shown that allergic rhinitis does not correspond to a single cytological expression. In some patients, established allergic sensitization coexists with recognized non-allergic cellular rhinitis entities, including non-allergic rhinitis with eosinophils (NARES), non-allergic rhinitis with mast cells (NARMA), and non-allergic rhinitis with eosinophils and mast cells (NARESMA), giving rise to the concept of overlapping rhinitis. This phenomenon challenges a binary allergic versus non-allergic classification and may contribute to difficult-to-treat disease and incomplete therapeutic responses. Although these nosological entities are clinically and cytologically defined, they should not be considered synonymous with molecular endotypes. Their future value may instead lie in a cytology-informed endotyping strategy integrating morphology with local biomarkers, proteomics, transcriptomics, and single-cell approaches. This Review discusses the cellular players and interactions shaping allergic rhinitis, the biological and clinical relevance of overlapping inflammation, and the potential role of nasal cytology as an interface between clinical phenotyping and molecular endotyping.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.